Background
==========

Extraskeletal osteosarcoma (ESOS), first defined in 1941 \[[@b1-medscimonit-26-e925107]\], is an extremely rare malignant mesenchymal tumor occurring in soft tissue without any skeletal attachment \[[@b2-medscimonit-26-e925107]\]. ESOS accounts for only 1% of soft tissue sarcomas and 2% to 4% of osteosarcomas \[[@b3-medscimonit-26-e925107],[@b4-medscimonit-26-e925107]\]. In contrast to conventional osteosarcoma, ESOS occurs frequently among elderly patients, and tumors are widely dispersed throughout the body \[[@b4-medscimonit-26-e925107],[@b5-medscimonit-26-e925107]\]. ESOS also has high rates of recurrence and distant metastasis, thus leading to poor prognosis \[[@b6-medscimonit-26-e925107]\].

Few studies of ESOS exist because of the low incidence of the disease, therefore, there is no consensus on a treatment protocol for it \[[@b6-medscimonit-26-e925107]--[@b8-medscimonit-26-e925107]\]. Surgical resection is the mainstay for treating ESOS \[[@b4-medscimonit-26-e925107]\]. Radiotherapy has been used in margin-positive resection \[[@b9-medscimonit-26-e925107]\]. Although chemotherapy is standard systematic treatment for osteosarcoma, its role in ESOS remains unclear \[[@b4-medscimonit-26-e925107],[@b5-medscimonit-26-e925107],[@b8-medscimonit-26-e925107]\]. Previous studies have reported that ESOS is insensitive to chemotherapy \[[@b7-medscimonit-26-e925107],[@b10-medscimonit-26-e925107]\], while a small number of studies suggested that chemotherapy improved prognosis \[[@b4-medscimonit-26-e925107],[@b8-medscimonit-26-e925107],[@b9-medscimonit-26-e925107]\]. To our knowledge, the role of chemotherapy in ESOS has not been well explored in a study with comparatively large sample size.

To gain an overview of patients with ESOS, related data were retrieved from the SEER database. We further analyzed prognostic factors for this rare tumor and the role of chemotherapy on survival of patients with ESOS.

Material and Methods
====================

Data sources and study population
---------------------------------

The SEER database collects individual cancer data from 18 registries, covering about 30% of the US population \[[@b11-medscimonit-26-e925107]\]. The cancer data include no personal identifying information and data acquisition are permitted by the National Cancer Institute. We collected individual cancer data from this database via SEER\*Stat software version 8.3.5.

We collected individual data on patients with ESOS from 1975 to 2016. Inclusion criteria were diagnosis of osteosarcoma according to ICD-O-3 histology code as the primary malignancy and limit of primary sites to extraskeletal sites according to the labeled primary site code. Data without positive histologic confirmation or exact follow-up time were excluded.

Covariates
----------

We extracted data on sociodemographic, tumor-related, and treatment-related characteristics. Patients with ESOS were classified as those treated with and without chemotherapy based on SEER treatment code. Age and tumor size were divided based on the median of the groups respectively. Labeled primary site code did not refer to specific tumor location due to the properties of the database. For example, soft tissues of fingers, hands, forearms, and upper arms were all defined as soft tissues in the upper limb (labeled primary code=C49.1). Therefore, there were a total of four different groups of sites, including extremities (soft tissues of upper and lower limbs), trunk (soft tissues of thorax, abdomen and pelvis), viscera (liver, cecum, pancreas, lung, ovary, kidney and other visceral organs), and other sites. We divided tumor grades based on degree of differentiation. Based on codes in the SEER database \[[@b12-medscimonit-26-e925107]\], tumor stages were further categorized into localized, regional, and distant. Primary endpoints were overall survival (OS) and cancer-specific survival (CSS) rate. OS was considered as the period from the time from diagnosis to death due to any cause. CSS was considered as the time from diagnostic confirmation until death from ESOS.

Statistical analyses
--------------------

Differences in sociodemographic, tumor-related, and treatment-related characteristics between patients treated with and without chemotherapy were assessed by Pearson's chi-squared test. We introduced multiple imputation by chained equations (MICE) to deal with missing data on tumor size with relevant values \[[@b13-medscimonit-26-e925107],[@b14-medscimonit-26-e925107]\]. Then we performed multivariable logistic regression to explore potential factors affecting selection of chemotherapy. Kaplan-Meier curve and log-rank test were calculated to compare OS and CSS rates in patients treated with and without chemotherapy. Comparison of each variable was analyzed by univariable Cox regression analysis. Variables closely approaching clinical significance (p\<0.1) were noted. Multivariable Cox regression models were created by adjusting for variables selected from the univariate analysis and other potential variables.

Inverse probability of treatment weighting (IPTW) and propensity score matching (PSM) with a 1: 1 ratio and a caliper of 0.01 were used to balance bias of confounding factors that may affect chemotherapy allocation \[[@b15-medscimonit-26-e925107],[@b16-medscimonit-26-e925107]\]. Multivariable logistic regression was performed to generate propensity scores (PS) for all variables, and then the weight was calculated and the matching was done based on the PS, respectively. We calculated standardized mean difference (SMD) to assess the balance of baseline characteristics after IPTW and PSM. IPTW-adjusted and PSM-adjusted Kaplan-Meier curves were drawn and comparisons of the treatments were analyzed with log-rank tests \[[@b17-medscimonit-26-e925107]\]. Landmark analysis was introduced to attenuate immortal time bias, if needed \[[@b18-medscimonit-26-e925107]\]. We then recreated IPTW-adjusted and PSM-adjusted multivariable Cox regression models and recalculated hazard ratios (HRs) \[[@b19-medscimonit-26-e925107]\]. Within the group of PSM, heterogeneity of chemotherapy treatment was evaluated via subgroup analysis according to variables including age, tumor site, stage, size, and surgery. We performed interaction tests to assess difference in the effect of chemotherapy between subgroups ([Supplementary Figure 1](#s1-medscimonit-26-e925107){ref-type="supplementary-material"}).

Pearson's chi-squared test, Logistic regression, and Cox regression analysis were conducted by SPSS (IBM, NY, United States). We created a Kaplan-Meier curve, performed a log-rank test, and created a forest plot presenting the results of subgroup analysis via GraphPad Prism 8 (GraphPad Software, Inc., CA, United States). MICE, IPTW, PSM, landmark analysis, bootstrap resampling, and interaction tests were conducted using R version 3.5.3 (*<http://www.r-project.org/>*). p\<0.05 that was two-sided was defined as statistical significance.

Results
=======

Characteristics associated with the use of chemotherapy
-------------------------------------------------------

Between 1976 and 2016, we identified 310 patients with ESOS who were histologically confirmed as having the primary malignancy. Among them, 153 (49.4%) received chemotherapy and 157 (50.6%) did not receive that treatment ([Supplementary Figure 1](#s1-medscimonit-26-e925107){ref-type="supplementary-material"}). Baseline characteristics of the original population with ESOS are presented in [Table 1](#t1-medscimonit-26-e925107){ref-type="table"}. The number of patients receiving chemotherapy increased over time while the proportion of different treatment groups was nearly equal ([Supplementary Figure 2](#s2-medscimonit-26-e925107){ref-type="supplementary-material"}). Based on propensity score, IPTW and PSM achieved optimal balance between the two treatment groups ([Table 1](#t1-medscimonit-26-e925107){ref-type="table"}, [Supplementary Table 1](#s3-medscimonit-26-e925107){ref-type="supplementary-material"}).

After IPTW and PSM, the majority of SMDs for all covariables in IPTW cohorts and PSW cohorts were less than 10%, also indicating that bias of confounding factors was attenuated ([Supplementary Figure 3](#s4-medscimonit-26-e925107){ref-type="supplementary-material"}). Multivariable logistic regression analysis identified characteristics significantly related to use of chemotherapy, including age ≥60 (odds ratio \[OR\], 0.57; 95% confidence interval \[CI\], 0.34--0.96; p=0.033), the trunk as primary tumor site (OR, 0.46; 95% CI, 0.25--0.85; p=0.012) and distant tumor stage (OR, 2.13; 95% CI, 1.02--4.44; p=0.044) ([Table 2](#t2-medscimonit-26-e925107){ref-type="table"}).

Treatment effect of chemotherapy on survival in different cohorts
-----------------------------------------------------------------

The 5-year OS rate was 45.4% (95% CI, 37.1--53.7%) in the group receiving chemotherapy and 40.0% (95% CI, 32.0--48.0%) in the group of patients treated without chemotherapy in the original unmatched cohort (p=0.073) ([Figure 1A](#f1-medscimonit-26-e925107){ref-type="fig"}). Likewise, no statistical significance was noted in the PSM-adjusted and IPTW-adjusted cohorts, which balanced the bias of confounding variables and made the treatment effect comparable ([Figure 1B, 1C](#f1-medscimonit-26-e925107){ref-type="fig"}). The 5-year OS was 42.8% (95% CI, 32.8--52.8%) for patients with chemotherapy and 38.5% (95% CI, 28.3--48.7%) for patients without chemotherapy in the PSM-adjusted cohort (P=0.402) and 45.5% (95% CI, 37.8--54.5%) for patients with chemotherapy and 40.5% (95% CI, 32.7--48.9%) for patients without chemotherapy in the IPTW-adjusted cohort (P=0.133). As landmark analysis in the PSM cohort illustrated that immortal time bias was controlled and no significant difference was noted in the effect of chemotherapy on prognosis of the two treatment groups at different time periods. ([Supplementary Figure 4](#s5-medscimonit-26-e925107){ref-type="supplementary-material"}). No statistical significance in CSS rate was noted in the original unmatched cohort, with a 5-year CSS rate of 51.7% (95% CI, 43.3--60.1%) in the chemotherapy group and 50.0% (95% CI, 41.4--58.6%) in the non-chemotherapy group (P=0.417) ([Figure 1D](#f1-medscimonit-26-e925107){ref-type="fig"}). There was still no significant statistical difference in CSS rate after adjustment for PSM- (P=0.423) and IPTW-adjustment (P=0.349) in these cohorts ([Figure 1E, 1F](#f1-medscimonit-26-e925107){ref-type="fig"}).

Prognostic characteristics for survival of ESOS
-----------------------------------------------

In the univariable Cox regression model for OS rate of the original unmatched cohort ([Table 3](#t3-medscimonit-26-e925107){ref-type="table"}), treatment with chemotherapy failed to reach statistical significance (Hazard Ratio \[HR\], 0.774; 95% CI, 0.583--1.027; p=0.076). Similarly, in multivariable Cox regression models, treatment with chemotherapy still had nothing to do with OS after adjusting for all characteristics in model 2 (HR, 0.723; 95% CI, 0.589--1.011; p=0.055) and the characteristics selected in the univariable Cox regression model (p\<0.1) including chemotherapy, age, race, marital status, primary sites, grade, stage, size, and surgery in model 1 (HR, 0.764; 95% CI, 0.555--1.051; p=0.098). The statistical significance of the characteristics in model 1 of the original unmatched group remained unchanged after 1000 bootstrap resamplings. In the IPTW cohort, use of chemotherapy did not improve OS in model 1 in multivariable Cox regression analysis adjusted for the characteristics mentioned above (HR, 0.737; 95% CI, 0.533--1.021; p=0.066) ([Supplementary Table 2](#s6-medscimonit-26-e925107){ref-type="supplementary-material"}). There was also no significant effect of chemotherapy on OS in model 1 of the PSM cohort adjusted for related characteristics (HR, 0.804; 95% CI, 0.552--1.172; p=0.257) ([Supplementary Table 3](#s7-medscimonit-26-e925107){ref-type="supplementary-material"}). For CSS rate between two groups, treatment with chemotherapy did not show significant therapeutic effect ([Supplementary Table 4](#s8-medscimonit-26-e925107){ref-type="supplementary-material"}).

In the multivariable Cox regression analysis adjusted for related characteristics for OS rate in the original unmatched cohort ([Table 3](#t3-medscimonit-26-e925107){ref-type="table"}), age ≥60 (HR, 2.095; 95% CI, 1.503--2.922; p\<0.001), the trunk (HR, 2.181; 95% CI, 1.488--3.197; p\<0.001) and the visceral (HR, 2.964; 95% CI, 1.951--4.505; p\<0.001) as the primary site of ESOS, the regional (HR, 1.718; 95% CI, 1.202--2.456; p=0.003) and the distant (HR, 2.456; 95% CI, 1.563--3.859; p\<0.001) tumor stage, tumor size ≥73 mm (HR, 3.374; 95% CI, 2.420--4.704; p\<0.001) and no surgical resection (HR, 2.302; 95% CI, 1.492--3.554; p\<0.001) were all reported as independent prognostic factors for OS of ESOS. Independent prognostic factors reported in the multivariable Cox regression models in IPTW and PSM cohorts remained virtually the same after adjustment for related characteristics ([Supplementary Tables 2](#s6-medscimonit-26-e925107){ref-type="supplementary-material"}, [3](#s7-medscimonit-26-e925107){ref-type="supplementary-material"}). Likewise, prognostic factors for OS rate remained statistically significant for CSS rate in patients with ESOS ([Supplementary Table 4](#s8-medscimonit-26-e925107){ref-type="supplementary-material"}). CSS rate was also significantly associated with grade III/IV disease (HR, 4.344; 95% CI, 1.346--14.023; p=0.014).

Treatment effect of chemotherapy on survival in subgroups
---------------------------------------------------------

Within subgroup analysis in the PSM-adjusted cohort, almost no significantly different treatment effects of chemotherapy were noted according to age, tumor sites, stage, size, or surgery ([Figure 2](#f2-medscimonit-26-e925107){ref-type="fig"}). Specifically, there was a statistical difference in the effect of chemotherapy in the group that had regional ESOS (HR, 0.538; 95% CI, 0.295--0.979; p=0.042). However, use of chemotherapy did not reach statistical significance in patients with localized ESOS that was (HR, 1.189; 95% CI, 0.668--2.115; p=0.556) and ESOS \<73 mm (HR, 1.011; 95% CI, 0.552--1.848; p=0.975). Of note, in patients with distant metastasis in the original unmatched cohort, chemotherapy failed to exert significant effect on OS and CSS rates ([Supplementary Figure 5A, 5C](#s9-medscimonit-26-e925107){ref-type="supplementary-material"}). The insignificant treatment effects were consistent in the PSM-adjusted cohorts of patients with distant metastasis ([Supplementary Figure 5B, 5D](#s9-medscimonit-26-e925107){ref-type="supplementary-material"}). We further performed interaction tests to analyze heterogeneity of the effect of chemotherapy in different subgroups. As illustrated in [Figure 2](#f2-medscimonit-26-e925107){ref-type="fig"}, no statistically significant difference was noted in interaction tests.

Discussion
==========

In recent decades, uncertainty has existed about the optimal treatment strategy for ESOS because of the extremely low incidence and limited number of studies \[[@b6-medscimonit-26-e925107],[@b20-medscimonit-26-e925107],[@b21-medscimonit-26-e925107]\]. Surgery is regarded as the mainstay for ESOS, which has improved prognosis, as reported in many studies \[[@b4-medscimonit-26-e925107],[@b9-medscimonit-26-e925107],[@b10-medscimonit-26-e925107],[@b21-medscimonit-26-e925107],[@b22-medscimonit-26-e925107]\]. As one of predisposing factors for ESOS, radiation therapy was not universally included in conventional treatment and the effect of radiation therapy was limited \[[@b6-medscimonit-26-e925107],[@b23-medscimonit-26-e925107],[@b24-medscimonit-26-e925107]\]. Nevertheless, little was known about the effect of chemotherapy on prognosis of ESOS, and its role is still contentious \[[@b4-medscimonit-26-e925107]--[@b6-medscimonit-26-e925107],[@b9-medscimonit-26-e925107],[@b20-medscimonit-26-e925107]--[@b22-medscimonit-26-e925107],[@b24-medscimonit-26-e925107]\]. Inconsistent results of treatment with chemotherapy may be explained by the relatively small sample size and bias of related studies \[[@b5-medscimonit-26-e925107],[@b25-medscimonit-26-e925107],[@b26-medscimonit-26-e925107]\]. To address the aforementioned limitations, we conducted IPTW- and PSM-adjusted analysis of a sample of 310 patients with ESOS who were assigned to groups with chemotherapy or without chemotherapy. No significant prognostic improvement was noted in the group receiving chemotherapy. In addition, subgroup analysis indicated that the insignificant treatment effect was consistent across all different subgroups. Several independent prognostic factors for ESOS were also identified through multivariable COX regression analysis. There are some noteworthy findings in the current study.

This study represents large cohorts of ESOS with 310 patients included based in the SEER database from 1976 to 2016. Because of the low incidence of ESOS, the majority of published studies concerning ESOS were case reports \[[@b27-medscimonit-26-e925107]--[@b29-medscimonit-26-e925107]\]. Median age was 60 years in the current study and most tumors were high-grade (grade III/IV), which was consistent with the common characteristics of ESOS \[[@b20-medscimonit-26-e925107],[@b24-medscimonit-26-e925107]\]. The 5-year OS rate was 43.1% in current study, also comparable with those in previous studies with relatively large sample size of ESOS \[[@b6-medscimonit-26-e925107],[@b20-medscimonit-26-e925107]\]. During the different time periods, the ratio of patients treated with and without chemotherapy remained relatively unchanged. It is of great significance to investigate several influential factors associated with use of chemotherapy. Age-related comorbidities and dysfunction may increase the risk of chemotherapy-related complications and morbidities \[[@b30-medscimonit-26-e925107],[@b31-medscimonit-26-e925107]\]. The significantly negative effect of older age (≥60 years) on chemotherapy use was noted in the current study. However, the reason why chemotherapy was used less for ESOS in the trunk remains relatively unclear. The prognosis of osteosarcoma and soft tissue sarcomas with distant metastasis is poorer, and treatment options are more limited \[[@b32-medscimonit-26-e925107]\].

Chemotherapy, as one type of non-surgical treatment, is relatively favored in patients with distant metastases \[[@b33-medscimonit-26-e925107]\]. However, there was no significant benefit of chemotherapy on prognosis of ESOS in the current study. It has been reported that targeted agents can be used as treatment, but related information about that is still limited \[[@b34-medscimonit-26-e925107]\].

Based on the propensity scores calculated according to all the covariables that may mislead treatment allocation, allocation bias was largely attenuated \[[@b35-medscimonit-26-e925107]\]. The insignificant treatment effect of chemotherapy in the original cohort was also noted in the adjusted and matched groups on the basis of propensity scores. There are also several studies concerning treatment of ESOS in which chemotherapy had no effect on OS \[[@b6-medscimonit-26-e925107],[@b7-medscimonit-26-e925107],[@b9-medscimonit-26-e925107],[@b10-medscimonit-26-e925107],[@b22-medscimonit-26-e925107],[@b24-medscimonit-26-e925107],[@b25-medscimonit-26-e925107],[@b36-medscimonit-26-e925107],[@b37-medscimonit-26-e925107]\]. Although ESOS shares several similarities with conventional osteosarcoma in histology, the disease originates in various locations throughout the whole body and has very different clinicopathologic characteristics \[[@b10-medscimonit-26-e925107],[@b21-medscimonit-26-e925107],[@b25-medscimonit-26-e925107],[@b33-medscimonit-26-e925107]\]. The name of extraskeletal osteosarcoma may lead to a misperception about ESOS, as it is actually more like soft tissue sarcoma and insensitive to chemotherapy \[[@b21-medscimonit-26-e925107],[@b24-medscimonit-26-e925107]\]. It seemed that chemotherapy treatment impropved prognosis in one European study with 266 patients with ESOS \[[@b4-medscimonit-26-e925107]\]. However, the data in that study were collected from 16 centers throughout Europe where chemotherapy protocols were distinct, and ESOS was the secondary malignancy in 12 patients in that study. Univariable and further multivariable analysis without covariables matched or weighted may also lead to less reliable conclusions \[[@b15-medscimonit-26-e925107],[@b38-medscimonit-26-e925107]\]. Another study that reported the potential for improved benefit with chemotherapy in patients with ESOS included only 17 patients, whose mean age was only 44 years \[[@b8-medscimonit-26-e925107]\]. Interestingly, chemotherapy protocols in studies of ESOS are divided into type of osteosarcoma and type of soft tissue sarcoma, while controversy about optimal protocols still exists \[[@b4-medscimonit-26-e925107],[@b5-medscimonit-26-e925107],[@b8-medscimonit-26-e925107],[@b9-medscimonit-26-e925107],[@b21-medscimonit-26-e925107],[@b22-medscimonit-26-e925107],[@b25-medscimonit-26-e925107],[@b36-medscimonit-26-e925107],[@b37-medscimonit-26-e925107]\]. Chemotherapy-induced complications remain a major cause of morbidities in patients with malignancy, and especially those who are elderly \[[@b39-medscimonit-26-e925107],[@b40-medscimonit-26-e925107]\]. Considering the insignificant treatment effect on ESOS, chemotherapy may not be recommended as the conventional treatment in this disease.

In the current study, we also found that age ≥60 years, the trunk and viscera as the primary site of ESOS, regional and distant metastasis, size ≥73 mM, and no surgical resection were significantly related to poor prognosis of ESOS, which was also consistent in the IPTW and PSM cohorts. Soft tissue sarcomas in elderly patients tend to metastasize and relapse, but aggressive treatment is not suitable for those patients because of their age-related comorbidities and dysfunctions \[[@b30-medscimonit-26-e925107],[@b31-medscimonit-26-e925107]\]. In one study that included 43 patients with ESOS, tumors located in the viscera were reported to be associated with poorer prognosis \[[@b9-medscimonit-26-e925107]\]. As several studies about ESOS indicated, tumor depth may be one significant predictor of patient survival \[[@b6-medscimonit-26-e925107],[@b9-medscimonit-26-e925107],[@b21-medscimonit-26-e925107],[@b22-medscimonit-26-e925107],[@b24-medscimonit-26-e925107]\]. Compared with the lower and upper extremities, the trunk and abdominal cavity have the anatomical space and may allow more extension of soft tissue sarcomas, leading to poor prognosis in those sites \[[@b41-medscimonit-26-e925107]--[@b43-medscimonit-26-e925107]\]. The SEER historic stage was introduced in the current study while there was a lack of complete information about the American Joint Committee on Cancer (AJCC) stage system within SEER data because of the database design \[[@b12-medscimonit-26-e925107]\]. Distant metastasis of tumor was related to poor prognosis and ESOS is no exception \[[@b44-medscimonit-26-e925107]\]. The poor prognosis for regional ESOS still needs further research. Median tumor size ranged from 5.9 cm to 10 cm in related studies of ESOS, and was indicated to be a prognostic factor for poorer prognosis \[[@b9-medscimonit-26-e925107],[@b10-medscimonit-26-e925107],[@b21-medscimonit-26-e925107],[@b22-medscimonit-26-e925107],[@b36-medscimonit-26-e925107],[@b44-medscimonit-26-e925107]\]. Surgical resection may reduce tumor burden and improve survival and was regarded as optimal treatment for ESOS \[[@b4-medscimonit-26-e925107],[@b9-medscimonit-26-e925107],[@b10-medscimonit-26-e925107]\]. In the subgroup analysis, it is noteworthy that the insignificant treatment effect of chemotherapy was consistent across different subgroups. For patients with regional ESOS, chemotherapy seems to have a survival benefit. However, because analysis of five subgroups including 14 different characteristics suggested an insignificant treatment effect and all *p* for interaction \> 0.05, the effect of chemotherapy on ESOS at the regional stage still needs further study.

This study also had limitations in design and data. First, detailed information about chemotherapy including chemotherapy regimens, doses, and the specific number of cycles was not recorded in the SEER database. Therefore, we could not make further conclusion about the specific treatment effects of chemotherapy stratified by regimens and other elements. Similar limitations can also be found in high-quality studies in which the specific protocol for chemotherapy was missing \[[@b45-medscimonit-26-e925107],[@b46-medscimonit-26-e925107]\]. Second, although IPTW- and PSM-adjusted analysis are efficient for mitigating selection bias caused by observed cofounders, some unobserved cofounders, including specific surgical types, distant metastatic sites, and tumor necrosis rates, may have some effects on prognosis. Nevertheless, through systematic multiple analysis of 12 sociodemographic, tumor-related and treatment-related covariables, the insignificant treatment effect of chemotherapy was stable across all the cohorts. Third, we mainly concentrated on the treatment effect of chemotherapy on the OS and CSS in this study. Further study could include other aspects, such as treatment-related complications, treatment costs, and quality of life, to comprehensively assess patient status. Finally, this study is retrospective because of the properties of the SEER database \[[@b11-medscimonit-26-e925107]\]. However, it is not possible to conduct randomized controlled trials (RCT) of ESOS because of the epidemiological and clinical characteristics of the disease.

Conclusions
===========

To summarize, this study suggests no significant benefit for chemotherapy on prognosis of ESOS. This study represents a systemic assessment of the comparative effectiveness of chemotherapy and no chemotherapy in a large cohort of patients with ESOS. Although there are several limitations, including the retrospective design and lack of some treatment information, we believe that these findings should be given serious consideration when making treatment decisions for patients with ESOS.

Supplementary Data
==================

###### 

Study design. Data from patients with a histologically confirmed diagnosis of ESOS were extracted from the Surveillance Epidemiology and End Results (SEER) database (1975--2016), and then were analyzed according to the study design.

###### 

This graph illustrates use of chemotherapy for patients with ESOS over time in an original unmatched cohort from the SEER database, 1976 to 2016.

###### 

Sociodemographic and clinical characteristics of study patients after propensity score matching.

  Characteristic                     Overall (n=202)   Chemotherapy (n=101)   No chemotherapy (n=101)   P value
  ------------------- -------------- ----------------- ---------------------- ------------------------- ---------
  Age (year)          \<60           97 (48.0)         49 (48.5)              48 (47.5)                 1
  ≥60                 105 (52.0)     52 (51.5)         53 (52.5)                                        
  Gender              Male           91 (45.0)         46 (45.5)              45 (44.6)                 1
  Female              111 (55.0)     55 (54.5)         56 (55.4)                                        
  Race                White          163 (80.7)        81 (80.2)              82 (81.2)                 0.93
  Black               25 (12.4)      12 (11.9)         13 (12.9)                                        
  Other               14 (6.9)       8 (7.9)           6 (5.9)                                          
  Insurance type      Insured        66 (32.7)         32 (31.7)              34 (33.7)                 0.761
  Any medicaid        13 (6.4)       8 (7.9)           5 (5.0)                                          
  Unknown             123 (60.9)     61 (60.4)         62 (61.4)                                        
  Marital status      Single         35 (17.3)         18 (17.8)              17 (16.8)                 0.898
  Widowed/divorced    47 (23.3)      25 (24.8)         22 (21.8)                                        
  Married             113 (55.9)     54 (53.5)         59 (58.4)                                        
  Unknown             7 (3.5)        4 (4.0)           3 (3.0)                                          
  Year of diagnosis   1976 to 1985   16 (7.9)          7 (6.9)                9 (8.9)                   0.796
  1986 to 1995        28 (13.9)      12 (11.9)         16 (15.8)                                        
  1996 to 2005        63 (31.2)      33 (32.7)         30 (29.7)                                        
  2006 to 2016        95 (47.0)      49 (48.5)         46 (45.5)                                        
  Primary site        Extremity      84 (41.6)         41 (40.6)              43 (42.6)                 0.981
  Trunk               53 (26.2)      26 (25.7)         27 (26.7)                                        
  Visceral            37 (18.3)      19 (18.8)         18 (17.8)                                        
  Other               28 (13.9)      15 (14.9)         13 (12.9)                                        
  Grade               Grade I/II     12 (5.9)          6 (5.9)                6 (5.9)                   0.816
  Grade III/IV        134 (66.3)     65 (64.4)         69 (68.3)                                        
  Unknown             56 (27.7)      30 (29.7)         26 (25.7)                                        
  Stage               Localized      91 (45)           44 (43.6)              47 (46.5)                 0.972
  Regional            68 (33.7)      35 (34.7)         33 (32.7)                                        
  Distant             34 (16.8)      17 (16.8)         17 (16.8)                                        
  Unstaged            9 (4.5)        5 (5.0)           4 (4.0)                                          
  Tumor size (mm)     \<73           99 (49.0)         52 (51.5)              47 (46.5)                 0.574
  ≥73                 103 (51.0)     49 (48.5)         54 (53.5)                                        
  Radiation           Yes            54 (26.7)         25 (24.8)              29 (28.7)                 0.634
  No                  148 (73.3)     76 (75.2)         72 (71.3)                                        
  Surgery             Yes            175 (86.6)        86 (85.1)              89 (88.1)                 0.680
  No                  27 (13.4)      15 (14.9)         12 (11.9)                                        

mm -- millimeter.

###### 

Standardized mean differences (SMDs) of different cohorts are presented in this graph.

###### 

As is shown in the landmark analysis in this graph, there was no significant difference in the effect of chemotherapy on survival of two treatment groups at different time periods.

###### 

Cox regression models for OS in patients with ESOS in the IPTW cohort.

  Characteristic      Model 1[\*](#tfn11-medscimonit-26-e925107){ref-type="table-fn"} (weighted cohort)   Model 2[\*\*](#tfn12-medscimonit-26-e925107){ref-type="table-fn"} (weighted cohort)                                      
  ------------------- ----------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- ---------------------- ----------- ----
  Chemotherapy        No                                                                                  Reference                                                                             NA                     Reference   NA
  Yes                 0.737 (0.533--1.021)                                                                0.066                                                                                 0.735 (0.529--1.019)   0.065       
  Age(year)           \<60                                                                                Reference                                                                             NA                     Reference   NA
  ≥60                 2.066 (1.472--2.901)                                                                \<0.001                                                                               2.239 (1.575--3.183)   \<0.001     
  Gender              Male                                                                                                                                                                                             Reference   NA
  Female                                                                                                                                                                                        0.865 (0.578--1.294)   0.481       
  Race                White                                                                               Reference                                                                             NA                     Reference   NA
  Black               0,817 (0.448--1.491)                                                                0.509                                                                                 0.897 (0.488--1.648)   0.727       
  Other               0.679 (0.346--1.331)                                                                0.259                                                                                 0.649 (0.325--1.297)   0.221       
  Insurance type      Insured                                                                                                                                                                                          Reference   NA
  Any medicaid                                                                                                                                                                                  1.339 (0.639--2.803)   0.439       
  Unknown                                                                                                                                                                                       1.787 (0.869--3.673)   0.114       
  Marital status      Single                                                                              Reference                                                                             NA                     Reference   NA
  Widowed/divorced    1.238 (0.705--2.175)                                                                0.458                                                                                 1.361 (0.774--2.393)   0.285       
  Married             1.074 (0.624--1.847)                                                                0.798                                                                                 1.116 (0.645--1.929)   0.695       
  Unknown             2.824 (0.992--8.039)                                                                0.052                                                                                 2.222 (0.801--6.955)   0.171       
  Year of diagnosis   1976 to 1985                                                                                                                                                                                     Reference   NA
  1986 to 1995                                                                                                                                                                                  1.405 (0.754--2.621)   0.284       
  1996 to 2005                                                                                                                                                                                  0.903 (0.511--1.599)   0.727       
  2006 to 2016                                                                                                                                                                                  2.078(0.917--4.707)    0.079       
  Primary site        Extremity                                                                           Reference                                                                             NA                     Reference   NA
  Trunk               2.347 (1.605--3.433)                                                                \<0.001                                                                               2.559 (1.709--3.833)   \<0.001     
  Visceral            3.071 (1.918--4.919)                                                                \<0.001                                                                               3.384 (2.078--5.509)   \<0.001     
  Other               1.097 (0.593--2.029)                                                                0.769                                                                                 1.184 (0.637--2.202)   0.593       
  Grade               Grade I/II                                                                          Reference                                                                             NA                     Reference   NA
  Grade III/IV        1.383 (0.747--2.562)                                                                0.302                                                                                 1.235 (0.598--2.551)   0.568       
  Unknown             1.222 (0.643--2.323)                                                                0.541                                                                                 1.162 (0.579--2.334)   0.672       
  Stage               Localized                                                                           Reference                                                                             NA                     Reference   NA
  Regional            1.632 (1.139--2.37)                                                                 \<0.001                                                                               1.629 (1.119--2.371)   0.010       
  Distant             2.204 (1.376--3.532)                                                                \<0.001                                                                               2.311 (1.364--3.916)   0.002       
  Unstaged            1.114 (0.521--2.377)                                                                0.781                                                                                 1.093 (0.487--2.455)   0.829       
  Tumor size (mm)     \<73                                                                                Reference                                                                             NA                     Reference   NA
  ≥73                 3.969 (2.805--5.616)                                                                \<0.001                                                                               4.095 (2.840--5.904)   \<0.001     
  Radiation           Yes                                                                                                                                                                                              Reference   NA
  No                                                                                                                                                                                            0.757 (0.509--1.126)   0.169       
  Surgery             Yes                                                                                 Reference                                                                             NA                     Reference   NA
  No                  2.841 (1.716--4.701)                                                                \<0.001                                                                               3.049 (1.811--5.133)   \<0.001     

CI -- confidence interval; EOSS -- extraskeletal osteosarcoma; IPTW -- inverse probability of treatment weighting; NA -- not applicable; HR -- hazard ratio; mm -- millimeter; OSM -- osteosarcoma.

Multivariable Cox regression adjusted for chemotherapy, age, race, marital status, primary site, grade, stage, tumor size and surgery in the weighted cohort.

Multivariable Cox regression adjusted for all characteristics in the study of weighted cohort.

###### 

Cox regression models for OS in patients with ESOS in the PSM cohort.

  Characteristic      Model 1[\*](#tfn14-medscimonit-26-e925107){ref-type="table-fn"} (Matched cohort)   Model 2[\*\*](#tfn15-medscimonit-26-e925107){ref-type="table-fn"} (Matched cohort)                                      
  ------------------- ---------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ ---------------------- ----------- ----
  Chemotherapy        No                                                                                 Reference                                                                            NA                     Reference   NA
  Yes                 0.804 (0.552--1.172)                                                               0.257                                                                                0.814 (0.557--1.189)   0.287       
  Age (year)          \<60                                                                               Reference                                                                            NA                     Reference   NA
  ≥60                 1.782 (1.187--2.676)                                                               0.005                                                                                2.062 (1.304--3.259)   0.002       
  Gender              Male                                                                                                                                                                                           Reference   NA
  Female                                                                                                                                                                                      0.905 (0.583--1.403)   0.654       
  Race                White                                                                              Reference                                                                            NA                     Reference   NA
  Black               0.899 (0.486--1.663)                                                               0.735                                                                                0.962 (0.513--1.805)   0.905       
  Other               0.746 (0.286--1.946)                                                               0.551                                                                                0.773 (0.288--2.079)   0.611       
  Insurance type      Insured                                                                                                                                                                                        Reference   NA
  Any medicaid                                                                                                                                                                                1.661 (0.726--3.798)   0.229       
  Unknown                                                                                                                                                                                     1.915 (0.811--4.525)   0.138       
  Marital status      Single                                                                             Reference                                                                            NA                     Reference   NA
  Widowed/divorced    0.927 (0.506--1.698)                                                               0.806                                                                                0.954 (0.507--1.795)   0.884       
  Married             0.834 (0.482--1.442)                                                               0.516                                                                                0.862 (0.484--1.534)   0.612       
  Unknown             2.004(0.698--5.753)                                                                0.197                                                                                2.079 (0.655--6.601)   0.214       
  Year of diagnosis   1976 to 1985                                                                                                                                                                                   Reference   NA
  1986 to 1995                                                                                                                                                                                1.357 (0.644--2.863)   0.422       
  1996 to 2005                                                                                                                                                                                0.763 (0.376--1.546)   0.453       
  2006 to 2016                                                                                                                                                                                1.535 (0.588--4.005)   0.382       
  Primary site        Extremity                                                                          Reference                                                                            NA                     Reference   NA
  Trunk               2.148 (1.319--3.495)                                                               0.002                                                                                2.329 (1.389--3.904)   0.001       
  Visceral            2.521 (1.481--4.292)                                                               0.001                                                                                2.767 (1.577--4.853)   \<0.001     
  Other               0.881 (0.452--1.715)                                                               0.709                                                                                0.951 (0.477--1.889)   0.883       
  Grade               Grade I/II                                                                         Reference                                                                            NA                     Reference   NA
  Grade III/IV        1.015 (0.445--2.319)                                                               0.971                                                                                1.061 (0.452--2.486)   0.893       
  Unknown             0.886 (0.366--2.144)                                                               0.788                                                                                0.903 (0.365--2.237)   0.826       
  Stage               Localized                                                                          Reference                                                                            NA                     Reference   NA
  Regional            1.757 (1.105--2.793)                                                               0.017                                                                                1.762 (1.092--2.842)   0.021       
  Distant             2.626 (1.512--4.561)                                                               0.001                                                                                3.221 (1.773--5.849)   \<0.001     
  Unstaged            1.585 (0.702--3.581)                                                               0.268                                                                                1.582 (0.652--3.838)   0.311       
  Tumor size (mm)     \<73                                                                               Reference                                                                            NA                     Reference   NA
  ≥73                 4.571 (2.952--7.705)                                                               \<0.001                                                                              4.967 (3.132--7.878)   \<0.001     
  Radiation           Yes                                                                                                                                                                                            Reference   NA
  No                                                                                                                                                                                          0.641 (0.401--1.025)   0.063       
  Surgery             Yes                                                                                Reference                                                                            NA                     Reference   NA
  No                  3.957 (2.269--6.902)                                                               \<0.001                                                                              4.345 (2.432--7.763)   \<0.001     

CI -- confidence interval; ESOS -- extraskeletal osteosarcoma; NA -- not applicable; HR -- hazard ratio; mm -- millimeter; OSM -- osteosarcoma; PSM -- propensity score matched.

Multivariable Cox regression adjusted for chemotherapy, age, race, marital status, primary site, grade, stage, tumor size and surgery in the matched cohort.

Multivariable Cox regression adjusted for all characteristics in the study in the matched cohort.

###### 

Cox regression models for cancer-specific survival in patients with extraskeletal osteosarcoma in the unmatched cohort.

  Characteristic      Unadjusted[\*](#tfn17-medscimonit-26-e925107){ref-type="table-fn"} (Unmatched cohort)   Model 1[\*\*](#tfn18-medscimonit-26-e925107){ref-type="table-fn"} (Unmatched cohort)   Model 2[\*\*\*](#tfn19-medscimonit-26-e925107){ref-type="table-fn"} (Unmatched cohort)                                                   
  ------------------- --------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------- ----------- ----------------------- ----------- ----
  Chemotherapy        No                                                                                      Reference                                                                              NA                                                                                       Reference   NA                      Reference   NA
  Yes                 0.887 (0.637--1.236)                                                                    0.479                                                                                  0.765 (0.533--1.099)                                                                     0.147       0.727 (0.503--1.049)    0.088       
  Age (year)          \<60                                                                                    Reference                                                                              NA                                                                                       Reference   NA                      Reference   NA
  ≥60                 1.547 (1.107--2.163)                                                                    0.011                                                                                  1.672 (1.149--2.432)                                                                     0.007       1.680 (1.123--2.513)    0.012       
  Gender              Male                                                                                    Reference                                                                              NA                                                                                                                           Reference   NA
  Female              0.933 (0.670--1.299)                                                                    0.681                                                                                                                                                                                       0.922 (0.619--1.375)    0.692       
  Race                White                                                                                   Reference                                                                              NA                                                                                                                           Reference   NA
  Black               0.944 (0.567--1.571)                                                                    0.826                                                                                                                                                                                       1.219 (0.702--2.116)    0.482       
  Other               0.650 (0.303--1.395)                                                                    0.269                                                                                                                                                                                       0.825 (0.358--1.904)    0.652       
  Insurance type      Insured                                                                                 Reference                                                                              NA                                                                                                                           Reference   NA
  Any medicaid        1.201 (0.606--2.381)                                                                    0.600                                                                                                                                                                                       0.940 (0.427--2.070)    0.878       
  Unknown             0.853 (0.593--1.228)                                                                    0.392                                                                                                                                                                                       1.529 (0.697--3.357)    0.290       
  Marital status      Single                                                                                  Reference                                                                              NA                                                                                       Reference   NA                      Reference   NA
  Widowed/divorced    1.864 (1.074--3.236)                                                                    0.027                                                                                  1.573 (0.866--2.856)                                                                     0.137       1.682 (0.910--3.109)    0.097       
  Married             1.525 (0.924--2.517)                                                                    0.099                                                                                  1.440 (0.835--2.482)                                                                     0.190       1.410 (0.797--2.495)    0.238       
  Unknown             1.717 (0.584--5.053)                                                                    0.326                                                                                  2.123 (0.703--6.412)                                                                     0.182       1.739 (0.541--5.591)    0.353       
  Year of diagnosis   1976 to 1985                                                                            Reference                                                                              NA                                                                                                                           Reference   NA
  1986 to 1995        1.269 (0.578--2.787)                                                                    0.553                                                                                                                                                                                       1.422 (0.610--3.313)    0.415       
  1996 to 2005        0.950 (0.465--1.942)                                                                    0.888                                                                                                                                                                                       0.849 (0.391--1.843)    0.680       
  2006 to 2016        1.266 (0.629--2.549)                                                                    0.509                                                                                                                                                                                       1.809 (0.655--4.994)    0.253       
  Primary site        Extremity                                                                               Reference                                                                              NA                                                                                       Reference   NA                      Reference   NA
  Trunk               1.608 (1.051--2.460)                                                                    0.028                                                                                  1.953 (1.250--3.053)                                                                     0.003       2.138 (1.338--3.415)    0.001       
  Visceral            3.716 (2.416--5.717)                                                                    \<0.001                                                                                3.079 (1.914--4.952)                                                                     \<0.001     3.462 (2.069--5.791)    \<0.001     
  Other               1.108 (0.628--1.954)                                                                    0.724                                                                                  1.377 (0.731--2.593)                                                                     0.322       1.441 (0.748--2.778)    0.275       
  Grade               Grade I/II                                                                              Reference                                                                              NA                                                                                       Reference   NA                      Reference   NA
  Grade III/IV        4.738 (1.502--14.952)                                                                   0.008                                                                                  4.344 (1.346--14.023)                                                                    0.014       4.076 (1.250--13.297)   0.020       
  Unknown             4.923 (1.521--15.936)                                                                   0.008                                                                                  2.779 (0.838--9.220)                                                                     0.095       2.850 (0.850--9.558)    0.090       
  Stage               Localized                                                                               Reference                                                                              NA                                                                                       Reference   NA                      Reference   NA
  Regional            1.830 (1.218--2.751)                                                                    0.004                                                                                  1.543 (1.009--2.359)                                                                     0.045       1.718 (1.099--2.686)    0.018       
  Distant             4.142 (2.675--6.413)                                                                    \<0.001                                                                                2.717 (1.642--4.495)                                                                     \<0.001     3.255 (1.878--5.644)    \<0.001     
  Unstaged            3.274 (1.698--6.315)                                                                    \<0.001                                                                                1.673 (0.817--3.423)                                                                     0.159       1.957 (0.906--4.227)    0.088       
  Tumor size (mm)     \<73                                                                                    Reference                                                                              NA                                                                                       Reference   NA                      Reference   NA
  ≥73                 2.766 (1.947--3.931)                                                                    \<0.001                                                                                3.026 (2.066--4.432)                                                                     \<0.001     3.184 (2.153--4.710)    \<0.001     
  Radiation           Yes                                                                                     Reference                                                                              NA                                                                                                                           Reference   NA
  No                  0.977 (0.669--1.428)                                                                    0.906                                                                                                                                                                                       0.575 (0.367--0.901)    0.016       
  Surgery             Yes                                                                                     Reference                                                                              NA                                                                                       Reference   NA                      Reference   NA
  No                  2.894 (1.887--4.438)                                                                    \<0.001                                                                                2.533 (1.568--4.092)                                                                     \<0.001     2.729 (1.652--4.506)    \<0.001     

CI -- confidence interval; NA -- not applicable; HR -- hazard ratio; mm -- millimeter.

Univariable Cox regression analysis in the unmatched cohort.

Multivariable Cox regression adjusted for chemotherapy, age, marital status, primary site, grade, stage, tumor size and surgery in the unmatched cohort.

Multivariable Cox regression adjusted for all characteristics in the study in the unmatched cohort.

###### 

These graphs show Kaplan-Meier survival curves of overall survival and cancer-specific survival in (**A, C**) unmatched and (**B, D**) propensity score-matched cohorts of patients with distant metastasis.
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![These graphs show Kaplan-Meier survival curves of overall survival and cancer-specific survival in (**A, D**) unmatched, (**B, E**) propensity score matched, and (**C, F**) inverse probability of treatment weighting cohorts.](medscimonit-26-e925107-g001){#f1-medscimonit-26-e925107}
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###### 

Sociodemographic and clinical characteristics of study patients.

  Characteristic      Unweighted study population[\*](#tfn2-medscimonit-26-e925107){ref-type="table-fn"}                Weighted study population[\*\*](#tfn3-medscimonit-26-e925107){ref-type="table-fn"}                                             
  ------------------- ------------------------------------------------------------------------------------ ------------ ------------------------------------------------------------------------------------ ------------ ------- ------ ------ ------ -------
  Age(year)           \<60                                                                                 151 (48.7)   89 (58.2)                                                                            62 (39.5)    0.001   48.5   48     49     0.878
  ≥60                 159 (51.3)                                                                           64 (41.8)    95 (60.5)                                                                                         51.5    52     51            
  Gender              Male                                                                                 145 (46.8)   83 (54.2)                                                                            62 (39.5)    0.012   45.7   45.5   46     0.929
  Female              165 (53.2)                                                                           70 (45.8)    95 (60.5)                                                                                         54.3    54.5   54            
  Race                White                                                                                249 (80.3)   122 (79.7)                                                                           127 (80.9)   0.910   81.4   81.5   81.2   0.990
  Black               38 (12.3)                                                                            20 (13.1)    18 (11.5)                                                                                         11.4    11.4   11.3          
  Other               23 (7.4)                                                                             11 (7.2)     12 (7.6)                                                                                          7.2     7.1    7.5           
  Insurance type      Insured                                                                              111 (35.8)   54 (35.3)                                                                            57 (36.3)    0.379   36.9   36.3   37.6   0.978
  Any medicaid        22 (7.1)                                                                             14 (9.2)     8 (5.1)                                                                                           6.9     7      6.8           
  Unknown             177 (57.1)                                                                           85 (55.6)    92 (58.6)                                                                                         56.2    56.7   55.6          
  Marital status      Single                                                                               55 (17.7)    36 (23.5)                                                                            19 (12.1)    0.008   17.5   17.9   17.1   0.984
  Widowed/divorced    76 (24.5)                                                                            28 (18.3)    48 (30.6)                                                                                         24.5    24.7   24.3          
  Married             170 (54.8)                                                                           83 (54.2)    87 (55.4)                                                                                         54.5    54.3   54.7          
  Unknown             9 (2.9)                                                                              6 (3.9)      3 (1.9)                                                                                           3.5     3.1    3.9           
  Year of diagnosis   1976 to 1985                                                                         20 (6.5)     7 (4.6)                                                                              13 (8.3)     0.476   7      7.5    6.5    0.985
  1986 to 1995        36 (11.6)                                                                            18 (11.8)    18 (11.5)                                                                                         11.3    11.2   11.5          
  1996 to 2005        102 (32.9)                                                                           48 (31.4)    54 (34.4)                                                                                         31.5    31.8   31.2          
  2006 to 2016        152 (49)                                                                             80 (52.3)    72 (45.9)                                                                                         50.2    49.5   50.8          
  Primary site        Extremity                                                                            135 (43.5)   80 (52.3)                                                                            55 (35)      0.004   42.9   42.3   43.6   0.993
  Trunk               84 (27.1)                                                                            29 (19)      55 (35)                                                                                           27.7    28.5   26.9          
  Visceral            51 (16.5)                                                                            26 (17)      25 (15.9)                                                                                         15.9    15.9   15.8          
  Other               40 (12.9)                                                                            18 (11.8)    22 (14)                                                                                           13.5    13.3   13.7          
  Grade               Grade I/II                                                                           22 (7.1)     6 (3.9)                                                                              16 (10.2)    0.025   8.2    9.1    7.2    0.818
  Grade III/IV        203 (65.5)                                                                           110 (71.9)   93 (59.2)                                                                                         63.6    63.9   63.2          
  Unknown             85 (27.4)                                                                            37 (24.2)    48 (30.6)                                                                                         28.2    27     29.6          
  Stage               Localized                                                                            146 (47.1)   67 (43.8)                                                                            79 (50.3)    0.072   47.2   47.3   47.2   0.998
  Regional            96 (31)                                                                              43 (28.1)    53 (33.8)                                                                                         30.7    30.6   30.9          
  Distant             52 (16.8)                                                                            32 (20.9)    20 (12.7)                                                                                         17.1    17     17.4          
  Unstaged            16 (5.2)                                                                             11 (7.2)     5 (3.2)                                                                                           5       5      4.5           
  Tumor size (mm)     \<73                                                                                 155 (50)     70 (45.8)                                                                            85 (54.1)    0.173   49.2   48.2   50.3   0.742
  ≥73                 155 (50)                                                                             83 (54.2)    72 (45.9)                                                                                         50.8    51.8   49.7          
  Radiation           Yes                                                                                  73 (23.5)    40 (26.1)                                                                            33 (21)      0.349   24.6   24.7   24.4   0.956
  No                  237 (76.5)                                                                           113 (73.9)   124 (79)                                                                                          75.4    75.3   75.6          
  Surgery             Yes                                                                                  272 (87.7)   131 (85.6)                                                                           141 (89.8)   0.301   87.1   87.3   86.9   0.918
  No                  38 (12.3)                                                                            22 (14.4)    16 (10.2)                                                                                         12.9    12.7   13.1          

Mm -- millimeter.

Data are presented as number (percentage) of patients unless otherwise specified.

Data are presented as percentage of weighted study population unless otherwise specified.

###### 

Multivariable logistic regression model of characteristics associated with chemotherapy.

  Characteristic                         OR (95% CI)   P value
  ------------------ ------------------- ------------- ---------
  Age (year)         \<60                Reference     NA
  ≥60                0.57 (0.34--0.96)   0.033         
  Gender             Male                Reference     NA
  Female             0.72 (0.42--1.21)   0.209         
  Marital status     Single              Reference     NA
  Widowed/divorced   0.51 (0.23--1.16)   0.110         
  Married            0.63 (0.31--1.28)   0.201         
  Unknown            1.11 (0.23--5.31)   0.895         
  Primary site       Extremity           Reference     NA
  Trunk              0.46 (0.25--0.85)   0.012         
  Visceral           0.68 (0.32--1.42)   0.302         
  Other              0.57 (0.26--1.23)   0.151         
  Grade              Grade I/II          Reference     NA
  Grade III/IV       2.40 (0.84--6.86)   0.101         
  Unknown            1.55 (0.51--4.73)   0.443         
  Stage              Localized           Reference     NA
  Regional           0.85 (0.48--1.51)   0.575         
  Distant            2.13 (1.02--4.44)   0.044         
  Unstaged           2.96 (0.88--9.94)   0.080         

NA -- not applicable; OR -- odds ratio.

###### 

Cox regression models for overall survival in patients with extraskeletal osteosarcoma in the unmatched cohort.

  Characteristic      Unadjusted[\*](#tfn6-medscimonit-26-e925107){ref-type="table-fn"} (unmatched cohort)   Model 1[\*\*](#tfn7-medscimonit-26-e925107){ref-type="table-fn"} (unmatched cohort)   Model 2[\*\*\*](#tfn8-medscimonit-26-e925107){ref-type="table-fn"} (unmatched cohort)                                                  
  ------------------- -------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------- ----------- ---------------------- ----------- ----
  Chemotherapy        No                                                                                     Reference                                                                             NA                                                                                      Reference   NA                     Reference   NA
  Yes                 0.774 (0.583--1.027)                                                                   0.076                                                                                 0.764 (0.555--1.051)                                                                    0.098       0.723 (0.589--1.011)   0.055       
  Age(year)           \<60                                                                                   Reference                                                                             NA                                                                                      Reference   NA                     Reference   NA
  ≥60                 1.848 (1.384--2.468)                                                                   \<0.001                                                                               2.095 (1.503--2.922)                                                                    \<0.001     2.165 (1.521--3.082)   \<0.001     
  Gender              Male                                                                                   Reference                                                                             NA                                                                                                                         Reference   NA
  Female              0.953 (0.718--1.266)                                                                   0.742                                                                                                                                                                                     0.815 (0.576--1.155)   0.251       
  Race                White                                                                                  Reference                                                                             NA                                                                                      Reference   NA                     Reference   NA
  Black               0.804 (0.505--1.281)                                                                   0.359                                                                                 0.941 (0.572--1.546)                                                                    0.809       1.011 (0.612--1.668)   0.968       
  Other               0.578 (0.304--1.100)                                                                   0.095                                                                                 0.738 (0.374--1.456)                                                                    0.381       0.678 (0.339--1.356)   0.272       
  Insurance type      Insured                                                                                Reference                                                                             NA                                                                                                                         Reference   NA
  Any medicaid        1.244 (0.682--2.269)                                                                   0.477                                                                                                                                                                                     1.166 (0.591--2.307)   0.659       
  Unknown             0.786 (0.568--1.087)                                                                   0.146                                                                                                                                                                                     1.499 (0.737--3.045)   0.264       
  Marital status      Single                                                                                 Reference                                                                             NA                                                                                      Reference   NA                     Reference   NA
  Widowed/divorced    1.945 (1.226--3.084)                                                                   0.005                                                                                 1.501 (0.902--2.496)                                                                    0.118       1.631 (0.968--2.745)   0.066       
  Married             1.416 (0.926--2.164)                                                                   0.108                                                                                 1.196 (0.751--1.906)                                                                    0.451       1.186 (0.733--1.918)   0.487       
  Unknown             1.705 (0.655--4.439)                                                                   0.274                                                                                 2.104 (0.789--5.612)                                                                    0.137       1.657 (0.589--4.659)   0.338       
  Year of diagnosis   1976 to 1985                                                                           Reference                                                                             NA                                                                                                                         Reference   NA
  1986 to 1995        1.165 (0.621--2.188)                                                                   0.634                                                                                                                                                                                     1.476 (0.751--2.905)   0.261       
  1996 to 2005        0.952 (0.535--1.692)                                                                   0.867                                                                                                                                                                                     1.032 (0.553--1.927)   0.921       
  2006 to 2016        1.319 (0.745--2.338)                                                                   0.342                                                                                                                                                                                     2.195 (0.911--5.296)   0.081       
  Primary site        Extremity                                                                              Reference                                                                             NA                                                                                      Reference   NA                     Reference   NA
  Trunk               1.834 (1.287--2.611)                                                                   \<0.001                                                                               2.181 (1.488--3.197)                                                                    \<0.001     2.437 (1.632--3.638)   \<0.001     
  Visceral            3.642 (2.489--5.329)                                                                   \<0.001                                                                               2.964 (1.951--4.505)                                                                    \<0.001     3.337 (2.136--5.211)   \<0.001     
  Other               1.133 (0.703--1.826)                                                                   0.609                                                                                 1.382 (0.810--2.359)                                                                    0.235       1.442 (0.833--2.495)   0.191       
  Grade               Grade I/II                                                                             Reference                                                                             NA                                                                                      Reference   NA                     Reference   NA
  Grade III/IV        2.225 (1.088--4.553)                                                                   0.029                                                                                 2.102 (0.997--4.435)                                                                    0.051       1.907 (0.894--4.068)   0.095       
  Unknown             2.652 (1.266--5.555)                                                                   0.010                                                                                 1.706 (0.793--3.669)                                                                    0.172       1.768 (0.813--3.842)   0.151       
  Stage               Localized                                                                              Reference                                                                             NA                                                                                      Reference   NA                     Reference   NA
  Regional            1.801 (1.284--2.525)                                                                   \<0.001                                                                               1.718 (1.202--2.456)                                                                    0.003       1.791 (1.234--2.601)   0.002       
  Distant             3.495 (2.366--5.163)                                                                   \<0.001                                                                               2.456 (1.563--3.859)                                                                    \<0.001     2.661 (1.644--4.308)   \<0.001     
  Unstaged            2.806 (1.550--5.080)                                                                   \<0.001                                                                               1.523 (0.795--2.917)                                                                    0.205       1.588 (0.801--3.151)   0.186       
  Tumor size (mm)     \<73                                                                                   Reference                                                                             NA                                                                                      Reference   NA                     Reference   NA
  ≥73                 2.684 (1.993--3.613)                                                                   \<0.001                                                                               3.374 (2.420--4.704)                                                                    \<0.001     3.399 (2.423--4.769)   \<0.001     
  Radiation           Yes                                                                                    Reference                                                                             NA                                                                                                                         Reference   NA
  No                  1.116 (0.799--1.560)                                                                   0.519                                                                                                                                                                                     0.664 (0.452--0.976)   0.037       
  Surgery             Yes                                                                                    Reference                                                                             NA                                                                                      Reference   NA                     Reference   NA
  No                  2.553 (1.743--3.740)                                                                   \<0.001                                                                               2.302 (1.492--3.554)                                                                    \<0.001     2.434 (1.561--3.796)   \<0.001     

CI -- confidence interval; NA -- not applicable; HR -- hazard ratio; mm -- millimeter.

Univariable Cox regression analysis in the unmatched cohort.

Multivariable Cox regression adjusted for chemotherapy, age, race, marital status, primary site, grade, stage, tumor size and surgery in the unmatched cohort.

Multivariable Cox regression adjusted for all characteristics in the study in the unmatched cohort.
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